P ost-translational modifications (PTM) are important for modulating the function of proteins. In addition to phosphorylation, acetylation and methylation, O-linked Nacetylglucosamine (O-GlcNAc) modification is an important PTM of intracellular proteins 1 and is essential for mouse embryonic development 2 . O-GlcNAcylation is catalyzed by OGlcNAc transferase (Ogt) and is the addition of a GlcNAc unit to serine or threonine residues of nuclear and cytosolic proteins, and can be reversibly removed by O-linked N-acetylglucosaminidase (Oga) 3 . O-GlcNAcylation regulates many protein functions, including protein kinase activity, DNA-binding activity, protein-protein interaction, localization and stability, and has been implicated in diseases, including neurodegenerative diseases, diabetes, and cancers 4, 5 . Many proteins involved in neurodegenerative diseases, such as Alzheimer's disease-related tau protein and amyloid precursor protein, are modified by OGlcNAcylation, the reduction of which is associated with disease progression 6, 7 . Protein O-GlcNAcylation has also been shown to control T-cell progenitor renewal and malignancy 8 .
The maintenance of B-cell homeostasis depends on two central signals from the B-cell activating factor (BAFF) receptor (BAFFR) and B-cell receptor (BCR) 9, 10 . BAFF belongs to the TNF family, and is also known as TNF superfamily member 13B (TNFSF13B) 9 . Deletion of the gene encoding BAFF or BAFFR in mice results in the loss of the majority of peripheral mature B cells 11, 12 . BCR signaling is not only crucial for antigen-dependent activation of B cells, but also important for promoting survival mediated by ligand-independent tonic signals 13 . The PI3K/AKT signaling cascade has a critical function in the control of BCR-dependent mature B-cell survival 10 . After BCR ligation with antigen, phosphorylation of CD79a and CD79b, and the three main kinases downstream of BCR signaling (Syk, the Src family kinase Lyn, and the Tec-family kinase Btk) transduce crucial signaling events for the activation of B cells 14 .
Given that BCR-antigen engagement initiates a B-cell proliferation accompanied by rapid increases in glucose uptake and glycolysis 15 , which results in the generation of UDP-N-acetylglucosamine (UDP-GlcNAc) via the hexosamine biosynthetic pathway (HBP), and that UDP-GlcNAc is the donor substrate of Ogt 16 , we propose that O-GlcNAcylation may contribute to the function of B cells. Indeed, enhanced O-GlcNAcylation of transcription factors NF-κB p65 and NFATc1 by overexpression of Ogt in B or T cells results in increased cell activation 17 . Furthermore, our previous phosphoproteome-based analysis showed that phosphorylation of several proteins involved in BCR signaling was altered by the changes in protein O-GlcNAcylation 18 . However, the function of protein O-GlcNAcylation and Ogt in the B-cell lineage in vivo is unclear. Herein, we use genetically modified mouse models in which Ogt is deleted at different stages of B-cell development to study function in the B-cell lineage. We show that Ogt is not only important for triggering BCR-mediated signaling pathways, but also for the survival of mature, germinal center (GC) and post-GC B cells in vivo. A crucial role for OGlcNAcylation in IgG responses is also identified.
Results
Ogt is required for the homeostasis of mature B cells. To study whether Ogt has a function in B cells in vivo, we generated a mouse line in which Ogt can be deleted from pre-B cells, hereafter called B-KO, by crossing Ogt-floxed mice (Ogt f/f or Ogt f/ Y as Ogt is a X-linked gene 19 ) with mice expressing Cre recombinase controlled by the CD19 promoter (CD19-Cre) 20 . Deletion of Ogt is B-cell-specific as demonstrated by the intact Ogt allele in splenic CD3 + T cells ( Supplementary Fig. 1a ). In splenic B cells of B-KO mice, mRNA ( Supplementary Fig. 1b ) and protein (Supplementary Fig. 1c ) levels of Ogt were effectively decreased in comparison to littermate control (Ctrl) mice. Accordingly, overall protein O-GlcNAcylation was decreased in B-KO splenic B cells as compared with Ctrl splenic B cells (Fig. 1a) . Bone marrow B220 + B cells in B-KO mice also revealed efficient Ogt allele deletion ( Supplementary Fig. 1d ) and reduced mRNA (Supplementary Fig. 1e ). As Ogt is not completely deleted, we only used male mice in experiments to minimize the issue of mosaicism.
To examine whether absence of Ogt in B cells affects B-cell development, we analyzed the distribution and cellularity of B- (n = 3, a-d). *P < 0.05, **P < 0.01 (two-tailed unpaired t test). In e and f, the quantification of band intensity is indicated. N.S., not significant cell subsets in Ctrl and B-KO mice using the criteria described in Fig. 1b 21 . We found that both frequency and cell number of mature B cells, but not other stages of B cells, were largely decreased in the bone marrow of B-KO mice in comparison to Ctrl mice (Fig. 1c, d ). Given that mature B cells in bone marrow are re-circulating B cells, we also examined the B-cell subsets in the spleen and found that the frequency and numbers of total B220 + B cells were decreased (Fig. 1e, f) . The decreased number of splenic B cells appears to be due to the decreased number of mature B cells, particularly follicular (FO) B cells (Fig. 1e, f) but not other B-cell subsets, including immature B cells, transitional B cells (T1, T2 and T3), and marginal zone (MZ) B cells ( Fig. 1f and Supplementary Fig. 2a, b) .
Mature B cells in B-KO mice undergo increased apoptosis. In theory, if the reduced number of mature B cells is due to the developmental block, the number of immature or transitional B cells should be increased. However, B-KO mice showed normal number of immature and transitional B cells. We thus speculated that the reduced number of mature B cells in B-KO mice may result from enhanced apoptosis, which could reflect the insufficient acquisition of survival signals from the microenvironment. Therefore, we analyzed the frequency of apoptotic cells by Annexin V staining. In bone marrow, Annexin V + cells were increased among B220 + CD43 -non-pro-B cells, including late pre-B, immature B and mature B cells, in B-KO mice (Fig. 2a) . This increased apoptosis was prominent in re-circulating mature B cells, but not late pre-B or immature B cells, in which the Cd19 promoter-driven cre-recombinase should be also expressed ( Given that the survival of mature B cells depends on BAFFmediated signalling 9 , we next examined if the frequency of apoptosis differs in B cells from the bone marrow and spleen of Ctrl and B-KO mice when stimulated with recombinant BAFF (rBAFF). We found that rBAFF treatment of freshly isolated bone marrow or splenic B cells from Ctrl mice resulted in a more significant reduction in apoptosis compared with B-KO B cells (Fig. 2d ). This finding suggests that the BAFF signaling pathway may be perturbed in the absence of Ogt. BAFFR-mediated signaling activates several survival pathways including the activation of non-canonical NF-κB p52/RelB 22 , canonical NF-κB p50/RelA 23 , PI3K/AKT 24, 25 and ERK5 MAPK kinase 26 pathways. We found markedly reduced nuclear translocation of p50, RelA (p65), RelB and p52 in B-KO splenic B cells treated with rBAFF (Fig. 2e, Supplementary Fig. 3a) . Moreover, the activation of Erk5, p85 subunit of PI3K and Akt were also impaired in rBAFF-treated B-KO B cells (Fig. 2f , Supplementary  Fig. 3b ). It has been shown that BAFF regulates B-cell survival by downregulation of Bim 27 . Accordingly, we found that Bim levels were dramatically enhanced in rBAFF-treated B-KO B cells (Fig. 2f ). Together, this shows that BAFF-mediated mature B-cell survival is enhanced by Ogt.
Ogt deficient B cells have impaired activation. Appropriate tonic signaling via the BCR signalosome supports the survival of peripheral mature B cells 28 , whereas BCR cross-linking by antigen ligation employs similar signaling pathways to activate B cells and induce apoptosis 28 . We next sought to examine if B-KO B cells are more sensitive to apoptosis after cross-linking of BCR by antiIgM. We found that B-KO splenic B cells showed enhanced apoptosis when stimulated with anti-IgM compared with Ctrl B cells (Fig. 3a) . Interestingly, the effect of protein O-GlcNAcylation in preventing apoptosis appears to be specific to BCR signaling because lipopolysaccharide (LPS)-induced apoptosis via Toll-like receptor 4 (TLR4) was nearly comparable between Ctrl and B-KO B cells (Fig. 3a) . Thus, we wondered whether the activation of proximal BCR-mediated signaling pathways is perturbed in B-KO B cells. Indeed, we found that the phosphorylation of CD79a, Lyn, and Syk were all reduced in anti-IgM stimulated B-KO splenic B cells (Fig. 3b) , which was associated with the decreased nuclear translocation of various subunits of NF-κB (Fig. 3c , Supplementary Fig. 3c) . Furthermore, the activation of the PI3K/AKT pathway that transduces survival signals downstream of BCR cross-linking was also reduced in anti-IgM stimulated B-KO B cells (Fig. 3d, Supplementary Fig. 3d ).
The defective activation of the BCR signaling cascades was linked with markedly reduced B-cell activation in anti-IgM stimulated B-KO splenic B cells, as evidenced by the fact that the induction of B-cell activation surface markers, CD69 and CD86, was largely abolished (Fig. 3e) . Accordingly, 2 days after anti-IgM stimulation, the percentage of BrdU + B-KO B cells was largely reduced as compared with stimulated Ctrl B cells (Fig. 3f) . It is noted that Ogt may selectively affect BCR pathways because upregulation of CD69 and CD86, as well as cell proliferation, appear to be not significantly altered in LPS-treated B-KO splenic B cells (Fig. 3e, f) . All together, these results suggest that OGlcNAcylation is required for the initiation of antigen-ligation mediated BCR signaling.
BAFFR-mediated signaling has been demonstrated to cause CD79a and Syk phosphorylation via the activation of Src kinases such as Lyn 10 . We wondered if Lyn, CD79a and Syk phosphorylation is also affected in rBAFF-treated B-KO splenic B cells. Of note, we found the phosphorylation of Lyn, which links the crosstalk between BAFFR and BCR pathways, was defective, resulting in the reduced phosphorylation of CD79a and Syk in B-KO splenic B cells stimulated with rBAFF (Fig. 3g,  Supplementary Fig. 3e ).
O-GlcNAcylation of Lyn at S19 regulates Syk recruitment. We next attempted to decipher which molecules in BCR signaling are O-GlcNAcylated and are important for transducing critical signals for mounting proper B-cell activation. Cell lysates prepared from splenic B cells isolated from Ctrl and B-KO mice were subjected to a pull-down assay using succinylated wheat germ agglutinin (sWGA), a lectin that has high affinity for OGlcNAc 29 , followed by LC-MS/MS analysis ( Supplementary  Fig. 4a ). Comparing the proteome results from the pull-down assays with lysates from Ctrl and B-KO splenic B cells, we could identify the O-GlcNAcylated proteins of B cells (Supplementary Data 1). Proteins, including host cell factor 1 (HCF-1), specificity protein 1 (Sp1) and OGT, which have all previously been reported as O-GlcNAcylated proteins [30] [31] [32] , were readily detected by sWGA pull-down. Furthermore, Ingenuity Pathway Analysis (IPA) was used to construct systematic networks of O- GlcNAcylated proteins associated with BCR signaling. The results revealed that several proteins, including CD22, Lyn, and SHP-1 ( Supplementary Fig. 4b ), are relevant to BCR signaling pathways. Given that B-KO B cells displayed severe defects in responding to anti-IgM, we suspected that the function of certain proteins proximately associated with the BCR may be affected in the absence of O-GlcNAcylation. Indeed, we validated that Lyn was detected in the cell lysates by sWGA pull-down at various time points before and after anti-IgM stimulation ( Supplementary  Fig. 4c ). We also added GlcNAc together with sWGA to the lysates of unstimulated splenic B cells to demonstrate the signal specificity for O-GlcNAcylated proteins (Supplementary Fig. 4c ). Moreover, much less Lyn was pulled-down by sWGA from B-KO B cells than from Ctrl B cells (Supplementary Fig. 4d ). It is also noted that O-GlcNAcylation of Lyn affects its interaction with Syk because much less Lyn was co-immunoprecipitated with Syk from anti-IgM-treated splenic B-KO B cells than from Ctrl B cells (Fig. 4a) . Lack of O-GlcNAcylation did not affect the docking of Lyn and Syk to the cell membrane of stimulated B cells because similar amounts of Lyn and Syk were detected in the membrane fraction (Fig. 4b) . However, less Syk was associated with Lyn on the membrane of stimulated B-KO B cells (Fig. 4b) .
We then sought to definitively map the O-GlcNAcylated site(s) on Lyn by mass spectrometric analysis. Vectors expressing Flag-tagged Lyn and OGT were co-transfected into human embryonic kidney (HEK) 293T cells and Lyn purified by anti-Flag was subjected to LC-MS/MS to identify O-GlcNAcylation sites. O-GlcNAcylation-modified peptides of Lyn ( 7 RKDNLNDDEVDS GlcNAc KTQPVR 25 ) were observed at [M + 4 H] 4+ m/z 584.0374, and its O-GlcNAcylation at S19 was confirmed by both electron transfer dissociation (ETD) and higher collision energy dissociation fragmentation mass spectra ( Fig. 4c and Supplementary Fig. 4e) . A mutant Lyn, in which amino acid 19 is replaced by alanine (SA Lyn), was generated by site-directed mutagenesis. The results show that, compared with wild-type (WT) Lyn, SA Lyn expressed in HEK 293T cells failed to be pulled down by sWGA (Fig. 4d) . Moreover, coimmunoprecipitation results using lysates from HEK 293T cells expressing exogenous Flag-tagged WT or SA Lyn along with myctagged Syk showed that, compared with WT Lyn, SA Lyn interacts poorly with Syk (Fig. 4e) , supporting our notion that OGlcNAcylation of Lyn is important for the interaction with Syk. Of note, in response to anti-IgM cross-linking, less phosphorylated Flag-EGFP-tagged Lyn at tyrosine 397 that represents the active form 33 , was detected in transfected Ramos B cells when S19 was mutated to alanine (Fig. 4f) . Since phosphorylation of Lyn at S19 was observed in phagosomes in IFN-γ-activated macrophages 34 , we wondered if the less-efficient interaction between SA Lyn and Syk could result from impaired phosphorylation, rather than O-GlcNAcylation, at S19. To address this question, we further generated a mutant Lyn in which serine 19 was replaced with glutamic acid (SE Lyn), which acts as a phospho-mimicry mutation. Similar to SA Lyn, SE Lyn was neither pulled down by sWGA (Fig. 4d) nor co-immunoprecipitated with myc-tagged Syk (Fig. 4e) , demonstrating that loss of S19 O-GlcNAcylation, not phosphorylation, affects Syk interaction. Moreover, SE Lyn remained less activated after anti-IgM cross-linking in transfected Ramos B cells (Fig. 4f) . These combined results indicate that OGlcNAcylation of Lyn at S19 promotes Lyn activation and Syk interaction. 
NP-specific IgG1R.U GCs were randomly selected for counting). Representative data from one of at least two experimental repeats are shown. *P < 0.05, **P < 0.01, ***P < 0.001 (two-tailed unpaired t test)
Ogt is required for GC B cells and plasma cells. Fig. 5a ). The IgG1 + cells, gated from anti-IgM, anti-CD40, and IL-21 stimulated Cγ1-KO B cells, show enhanced apoptosis (Fig. 5a) Fig. 5b) . Accordingly, the size and numbers of peanut agglutinin (PNA) + B220 + GC B cells were reduced and the frequency of TUNEL + cells in spleens was increased in Cγ1-KO mice after NP-KLH immunization (Fig. 5c, d ).
Because of decreased survival of IgG1 + B cells, the levels of NPspecific IgG1 antibody were also greatly diminished in Cγ1-KO mice after primary and secondary immunization with NP-KLH (Fig. 5e) . Accordingly, the numbers of long-lived plasma cells secreting NP-specific antibody in bone marrow of Cγ1-KO mice at 4 weeks after secondary NP-KLH immunization were significantly reduced as compared with Ctrl mice (Fig. 5f) . Moreover, as the Cre-mediated recombination in IghCγ1-Cre mice occurs not only in IgG1 expressing B cells, but also in a fraction of B cells expressing other Ig isotypes 35 , we found that the titers of NP-specific IgG2b, IgG2c, and IgG3 were all reduced after NP-KLH immunization (Supplementary Fig. 5c ). These combined results suggest that O-GlcNAcylation is important for sustaining the survival of GC B cells and the production of antibodies.
Discussion O-GlcNAcylation modification serves as a nutrient sensor that regulates the signaling events in many physiological and diseased states 37 . In this study, we demonstrate that protein O-GlcNAcylation is not only required for mounting B-cell activation triggered by BCR ligation but also crucial for the maintenance of the survival of mature B cells, memory B cells and plasma cells.
Numerous reports demonstrate that O-GlcNAcylation plays a critical role in development and differentiation. However, reports focusing on the effects of O-GlcNAcylation on immune cell development and function are still very limited. In innate immune responses, O-GlcNAc modification of a regulatory subunit of transforming growth factor (TGF)-β-activated kinase 1 (TAK1), TAK1-binding protein 1 (TAB1), induces TAK1 autophosphorylation and activation, leading to NF-κB activation and cytokine production 38 . Recently, it was shown that protein O-GlcNAcylation is essential for T-cell development, as ablation of Ogt in T cells in vivo leads to a block of T-cell development in the thymus 8 . Furthermore, protein O-GlcNAcylation is also important for the clonal expansion of mature T cells, particularly T-cell receptor (TCR)-primed CD8 + T cells 8 . Whether T and B cells employ parallel O-GlcNAcylated proteins in TCR-or BCRmediated activation, respectively, remains unknown. It is plausible that Src family members in TCR signaling could also be OGlcNAcylated and transduce critical signals for T-cell activation and proliferation. Given that TLR-mediated B-cell activation and proliferation is not affected in B cells lacking Ogt, we suspected that the effect of protein O-GlcNAcylation on B-cell activation may act in a pathway-dependent manner. Nevertheless, combining our data and previous findings in the literature, it appears that both TCR-and BCR-mediated activation could promote changes in protein O-GlcNAcylation, which is required for lymphocyte activation.
In addition to being crucial for B-cell activation after BCR ligation with antigen, protein O-GlcNAcylation is also involved in BAFFR-mediated mature B-cell survival. However, the development of both FO and MZ B cells has been shown to highly rely on BAFF and BAFFR 11, 12 , which is partially inconsistent with the observed normal development of MZ B cells in B-KO mice. We suspect that lack of O-GlcNAcylation in other pathways may compensate for defects of BAFF signaling in MZ B cells in B-KO mice. Nevertheless, we found that several pathways downstream of ligation of BAFF and BAFFR, including the ERK5, PI3K/AKT, canonical and non-canonical NF-κB pathways, are all affected in the absence of Ogt in mature B cells. Interestingly, mice lacking Erk5 specifically in B cells also exhibited reduced number of mature B cells in bone marrow and spleen, like B-KO mice 26 . Why does a lack of Ogt selectively affect mature B-cell homeostasis? We think it is unlikely to be a result of the higher expression levels of Ogt or Oga in mature B cells because comparable levels of Ogt and Oga mRNAs were detected in various stages of development of bone marrow B cells ( Supplementary  Fig. 6 ). Identification of the important O-GlcNAcylated proteins in BAFFR-mediated signaling is awaited. It is possible that proteins that differentially lost O-GlcNAc modification in the B-KO splenic B cells identified here may also regulate the BAFFR signalosome. The Src family kinase Lyn is suggested to bridge BAFFR and BCR signaling in maintaining mature B-cell survival 10 . We found that O-GlcNAcylation of Lyn affects its interaction with Syk, and thus may be one possible underlying mechanism.
O-GlcNAcylation elevation by treatment with an OGA inhibitor, PUGNAc, or overexpression of OGT enhances and accelerates lymphocyte activation, which may be due to the increased O-GlcNAcylation of NF-ATc1 and NF-κB that causes their translocation to the nucleus 17 . Similarly, we previously demonstrated that O-GlcNAc accumulation after treatment with another OGA inhibitor, thiamet-G, enhances B-cell activation 18 . Consistently, using B-cell-specific Ogt knockout B cells, we demonstrate that O-GlcNAcylation is required for B-cell activation. Moreover, in this study, we further reveal the O-GlcNAcylated proteins that are important for the regulation of B-cell activation. We show that O-GlcNAcylation of Lyn at S19 is important for transducing signals required for B-cell activation. Phosphorylation of Lyn at S19 was present in activated macrophages 34 . However, the function of phosphorylation of Lyn at S19 and whether phosphorylation of Lyn at S19 has a competitive interplay with O-GlcNAcylation at the same site has not been demonstrated. Although our results demonstrate that SE Lyn interacts poorly with Syk and shows reduced activation after BCR cross-linking as compared with WT Lyn, we cannot directly answer whether there is a competitive interplay between OGlcNAcylation and phosphorylation on S19 of Lyn. Interestingly, S19 lies adjacent to a conserved and functionally important caspase cleavage site, aspartic acid 18 (D18), in Lyn, which is involved in Fas-and anti-IgM-triggered apoptosis 39, 40 . Notably, the cleaved form of Lyn inhibits BCR-triggered apoptosis 40 . It is possible that O-GlcNAc modification of S19 may affect caspase-mediated cleavage at D18, consequently modulating the outcome of apoptosis in B cells. S19 is not conserved in human Lyn; it is thus worthwhile to identify O-GlcNAc sites on human Lyn to further elucidate the underlying mechanisms of the functional effects of O-GlcNAcylation in human Lyn. Nevertheless, our result suggests that O-GlcNAcylation of Lyn is critical for the interaction with Syk and activation of Lyn in BCR activation, which may contribute to the homeostasis and activation of B cells in mice and perhaps other organisms. In addition to Lyn, we identified several other putative O-GlcNAcylated molecules in B cells. Many of these proteins are either within the BCR signalosome or important for B-cell function. The identification of the O-GlcNAcylated sites on these proteins and their relevance to Bcell activation may further advance our understanding of the functions of protein O-GlcNAcylation in B-cell activation.
Using Cγ1-KO mice, we could show that GC and memory B cells have increased levels of apoptosis, which is linked with the reduced production of antigen-specific antibody and long-lived plasma cells. The mechanisms causing the impaired formation of GC and maintenance of the survival of memory B cells as well as long-lived plasma cells in Cγ1-KO mice could also be defective BAFF and its receptor-mediated signaling pathways because BAFFR is also abundantly expressed by memory B cells and the expression of two other receptors for BAFF, cyclophilin ligand interactor (TACI) and B-cell maturation antigen (BCMA), are induced following the differentiation of plasma cells 41 .
Altogether, we demonstrate a role for Ogt and protein OGlcNAcylation in the maintenance of the homeostasis of mature B cells, memory B cells, and plasma cells. O-GlcNAcylation at S19 of Lyn is also crucial for provoking the activation of B cells after cross-linking of the BCR. Given that expression of X-linked genes, including OGT, is increased in women with lupus 42 , our finding may be relevant to the design of new strategies for the control of autoimmune diseases.
Methods
Mice. Ogt f/f and Ogt f/ Y [2] mice were purchased from The Jackson Laboratory and crossed to CD19 Cre/+ or IgHCγ1 Cre/+ transgenic mice, both from The Jackson Laboratory. All mice were on a C57BL/6 background. Mice were maintained in specific pathogen-free condition in the animal facility of Institute of Cellular and Organismic Biology at Academia Sinica. All animal procedures were approved by the Institutional Animal Care and Utilization Committee of Academia Sinica. Only 6-to 8-week-old male mice were used in experiments. Due to the limitation of the availability of knockout mice and their littermate control mice, no randomization was used. Mouse experiments were not blinded. Sample size for animal experiments was decided based on prior data generated in the laboratory and guidelines for "3 Rs" of animal research. No mouse was excluded from the analyses. Primer sequences for semi-quantitative PCR analysis of Ogt genomic DNA are: 5′-CATC TCTCCAGCCCCACAAACTG-3′ and 5′-GACGAAGCAGGAGGGGAGAGCA C-3′; Il-2: 5′-CTAGGCCACAGAATTGAAAGATCT-3′ and 5′-GTAGGTGGAAA TTCTAGCATCATCC-3′; Selp: 5′-TTGTAAATCAGAAGGAAGTGG-3′ and 5′-C GAGTTACTCTTGATGTAGATCTCC-3′.
Cell culture. 293 T (ATCC CRL-3216) cells were maintained in DMEM (Life Technologies) containing 10% FBS, 100 U ml −1 penicillin and 100 μg ml −1 streptomycin at 37°C with 5% CO 2 . Human Ramos B cells were purchased from Bioresource Collection and Research Center, Taiwan (BCRC) (BC-60252) and were cultured in RPMI 1640 medium (Life Technologies) containing 10% FBS, 100 U ml −1 penicillin and 100 μg ml −1 streptomycin (Life Technologies) at 37°C with 5% CO 2 . All the cell lines used in this study were confirmed to be free from mycoplasma contamination by using EZ-PCR mycoplasma test kit (Biological Industries). Mouse bone marrow B cells or splenic B cells purified from 6-to 8-week-old mice were isolated by anti-B220 magnetic beads (Miltenyi Biotec) and cultured in RPMI 1640 medium with 10% charcoal/dextran-treated FBS, 100 U ml −1 penicillin, 100 μg ml −1 streptomycin, and 50 μM 2-ME at 37°C with 5% CO 2 . Recombinant BAFF (rBAFF, 200 ng ml −1 ) (Peprotech) was added to bone marrow or splenic B cells (2 × 10 6 cells per ml) for 72 h. Mouse splenic B cells (2 × 10 6 cells per ml) were stimulated with 10 μg ml −1 goat-anti mouse IgM F(ab′) 2 (Jackson ImmunoResearch Laboratories), 2 μg ml −1 LPS (Sigma), or 1 μg ml −1 antimouse CD40 (BD Biosciences), 25 μg ml −1 goat-anti-mouse IgM (μ chain specific, Jackson ImmunoResearch Laboratories) plus 200 ng ml −1 recombinant mouse IL-21 (Affymetrix eBioscience). For BrdU labeling, 10 μM BrdU (BD Biosciences) was added into stimulated splenic B cells for 1 h before collecting the cells for flow cytometric analysis. Ramos B cells were stimulated by the treatment with goat antihuman IgM F(ab′) 2 (25 μg ml −1 ) (Jackson ImmunoResearch Laboratories) for 5 min.
Flow cytometry. Cells from spleen and bone marrow were isolated and stained as follows 43 : single-cell suspensions, prepared by 20 μg ml −1 Liberase Blendzyme II (Roche Applied Science) treatment for 20 min at room temperature, were washed with RPMI 1640 (Invitrogen) containing 50 μg ml −1 DNase I (Roche Applied Science) and 3% FBS, followed by removal of RBCs by RBC lysis buffer (SigmaAldrich). Bone marrow cells were flushed from tibias and femurs with medium with a syringe equipped with 26 G guage needle and filtered through cell strainer (BD Falcon). Fluorescence intensity was analyzed by FACScanto (BD Biosciences) and results were analyzed using FCS Express 3.0 software. In some experiments, B cells were sorted by FACS Aria (BD Biosciences). Primary antibodies used in this study are: APC-Cy7 (allophycocyanin-Cy7)-conjugated anti-mouse B220 (clone1:1000), anti-PI3K p85 (Cell Signaling, #4228, 1:1000), anti-phospho-AKT (Ser473) (Cell Signaling, #9271, 1:1000), anti-AKT (Cell Signaling, #9272, 1:1000), antiphospho-CD79a (Tyr182) (Cell Signaling, #5173, 1:1000), anti-CD79a (Abcam, ab3121, 1:1000), anti-Bim (Millipore, AB1770S, 1:1000), anti-Erk5 (Cell Signaling, #3372, 1:1000), anti-calnexin (Santa-Cruz, sc-6465, 1:1000), anti-OGT (Genetex, GTX30868, 1:1000), anti-actin (Sigma, A2228, 1:5000), anti-tubulin (Thermo, MS-581, 1:1000), anti-Flag (Sigma, F3165, 1:1000), and anti-myc (GenScript, A00172, 1:1000). Secondary antibodies used in immunoblotting are goat anti-mouse IgG horseradish peroxidase (HRP)-conjugated antibody (Sigma, A2554, 1:5000), goat anti-rabbit IgG HRP-conjugated antibody (Sigma, A0545, 1:5000) and rabbit antigoat IgG HRP-conjugated antibody (Sigma, A5420, 1:5000). Goat anti-mouse IgG light-chain-specific antibody conjugated with HRP (Millipore, AP200P, 1:5000) was used to prevent the interference of heavy chain signal after immunoprecipitation. Western Bright Sirius chemiluminescent detection reagent (Advansta, R-030027-C50) was used to detect the immunoreactive protein signals. Chemiluminescent signal images were captured by using LAS 3000 system (Fujifilm). All the immunoblotting experiments were performed at least twice and the representative results were shown. Full-length uncropped blots are presented in Supplementary Figs. 7-11 .
RT-qPCR. Total RNA was isolated by using RNeasy mini kit (Qiagen). The collected RNAs were reverse-transcribed to first-strand cDNA by High-Capacity cDNA Reverse Transcriptase kit (Life Technology) according to the manufacturer's suggestions. RT-qPCR analysis was subsequently performed by using Power SYBR Green PCR Master Mix (Life Technology) with the ABI prism 7300 sequence detection system (Life Technology). Primer sequences for RT-qPCR analysis of Ogt mRNA are: 5′-GCACGCATTTTTGACAGAGCT-3′ and 5′-GGCTCAAACTTAA GGCACGAA-3′, Oga mRNA are: 5′-GCAAGAGTTTGGTGTGCCTCATC-3′ and 5′-GTGCTGCAACTAAAGGAGTCCC-3′, and β-actin mRNA are: 5′-GCTGTA TTCCCCTCCATCGTG-3′ and 5′-CACGGTTGGCCTTAGGGTTCAG-3′.
Nano LC-MS/MS analysis. To investigate O-GlcNAc-ome of B cells, 450 μg lysates prepared from mouse splenic B cells of Ctrl and B-KO mice were collected and pulled down by 80 μl of sWGA agarose at 4°C for overnight using lysis buffer and elution buffer noted in methods for Immunoprecipitation and immunoblotting. To identify mouse Lyn O-GlcNAc site, Flag-tagged mouse Lyn protein, expressed and purified from overexpressed 293T cells as noted in Methods section for Immunoprecipitation and immunoblotting, was subjected to SDS-PAGE, followed by in gel digestion for following mass spectrometric analysis.
The MS data were acquired on an Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific) equipped with Ultimate 3000 RSLC system from Dionex (Dionex Corporation) and nanoelectrospry ion source (New Objective, Inc.). Samples in 0.1% formic acid were injected onto a self-packed precolumn (150 µm I.D. × 30 mm, 5 µm, 200 Å) at the flow rate of 10 μl min −1 . Chromatographic separation was performed on a self-packed reversed phase C18 nano-column (75 μm I.D. × 200 mm, 3 μm, 100 Å) using 0.1% formic acid in water as mobile phase A and 0.1% formic acid in 80% acetonitrile as mobile phase B operated at the flow rate of 300 nl min −1 . The MS/MS were run in top speed mode with 3 s cycles; while the dynamic exclusion duration was set to 60 s with a 25 ppm tolerance around the selected precursor and its isotopes. Monoisotopic precursor ion selection was enabled and 1 + charge state ions were rejected for MS/MS. The MS/MS analyses were carried out with the collision induced dissociation (CID) mode. Full MS survey scans from m/z 300 to 1600 were acquired at a resolution of 120,000 using EASY-IC as lock mass for internal calibration. The scan range of MS/MS spectra based on CID fragmentation method were from m/z 150-2000. The precursor ion isolation was performed with mass selecting quadrupole, and the isolation window was set to m/z 2.0. The automatic gain control (AGC) target values for full MS survey and MS/MS scans were set to 2e6 and 5e4, respectively. The maximum injection time for all spectra acquisition was 200 ms. For CID, the normalization collision energy (NCE) was set to 30%.
For data analysis, all MS/MS spectra were converted as mgf format from experiment RAW file by msConvert then analyzed by Mascot for MS/MS ion search. The search parameters included the error tolerance of precursor ions and the MS/MS fragment ions in spectra were 10 ppm and 0.6 Da and the enzyme was assigned to be trypsin with the miss cleavage number three. The variable PTMs in search parameter were assigned to include the oxidation of methionine and carbamidomethylation of cysteine. To delineate the role of O-GlcNAcylated proteins in BCR signaling, the sWGA pull-down proteins identified at <5% false discovery rate (FDR) with the ion score cut-off value 24 from Mascot search were analyzed by Ingenuity Pathway Analysis (IPA) to construct the O-GlcNAc-ome of B cells.
BrdU labeling in mice. Ctrl and B-KO mice were treated with BrdU (2 mg, BD Biosciences, San Jose, CA, USA) by intraperitoneal injection and euthanized 12 h later to examine the rate of BrdU incorporation in bone marrow mature B cells.
Mouse immunization and antibody analyses. Mice were immunized with 100 μg NP 32 -KLH (Biosearch Technologies, Petaluma, CA, USA) via intraperitoneal injection. Four weeks after primary immunization, mice were injected with 100 μg NP 32 -KLH for the secondary immunization. In one experiment, bone marrow cells (1 × 10 6 cells) isolated from Ctrl and Cγ1-KO mice at 4 weeks after the secondary immunization with NP-KLH were subjected to ELISPOT analysis to test the number of NP-specific IgG-secreting plasma cells as follows 44 : B cells were seeded into a 96-well plate and incubated on nitrocellulose membranes (Bio-Rad), which was coated with NP 32 -BSA (100 μg ml −1 , Biosearch technologies), at 37°C for 2.5 h. Attached cells were lysed by PBS-EDTA for 15 min, followed by two washes with 0.1% Tween 20 in PBS and one wash in PBS. The membrane was incubated at room temperature for 30 min with PBS and 1% bovine serum albumin (BSA), followed by incubation with anti-mouse IgG (Southern Biotechnology) at a dilution of 1000 × in PBS plus 1% BSA at room temperature for 1 h. NP-specific IgGsecreting cells were then visualized by the addition of enzyme substrate. Photomicrographs of the spots were analyzed with an AID EliSpot Reader (AID Autoimmun Diagnostika GmbH, Strassberg, Germany). Sera collected at various days after immunization were subjected to ELISA analysis as follows 44 : serially diluted sera were added onto NP 32 -BSA (100 μg ml −1 , Biosearch technologies) coated plates at 4°C for overnight, followed by detection with 5 μg ml −1 , 156.25 ng ml −1 , 2.5 μg ml −1 and 1.25 μg ml −1 horseradish-peroxidase-conjugated anti-mouse-IgG1, IgG2b, IgG2c, and IgG3 (Bethyl Laboratories), respectively. The absorbance at 450 nm was measured using a microplate reader (SpectraMax M2, Molecular Device, Sunnyvale, CA, USA).
Immunohistochemical and TUNEL staining. Two weeks after immunization, isolated mouse spleens were fixed by 10% formaldehyde and embedded in paraffin. Sections, sliced at 3 μm thickness, were dewaxed and incubated with retrieval solution (pH 9; DakoCytomation) with heating (95°C for 20 min). After blocking with 3% human serum (Invitrogen), slides were incubated with biotinylated PNA (1:100; Vector Laboratories) at 4°C for overnight and then immersed in streptavidin-alkaline phosphatase (1:500; Vector Laboratories) followed by color development with NBT/BCIP substrates (Roche). After washing with tap water, slides were incubated with anti-B220 antibody (1:200; Abcam) at 4°C for overnight. Immunoreactive signals were visualized by incubating with anti-rat IgG conjugated with HRP (Sigma) followed by color development with DAB (DAKO). For quantification of GC B cells, spleen sections were analyzed. In each section, five GCs were randomly selected for counting PNA + cells in fixed area (400 × 400 μm).
For TUNEL staining, mice were killed 2 weeks after immunization. Spleens were collected and fixed in 10% formaldehyde (Mallinckrodt Chemicals) at 4°C, and further processed for paraffin embedding. Samples sections were prepared at a thickness of 3 μm. Subsequent TUNEL staining was performed with an in situ cell death detection kit, Fluorescein (Roche) according to the manufacturer's suggestions. Images were acquired by Leica DMG000B microscope equipped with a 20 × /0.7 HC-Plan APO objective and Leica DFC490 camera and were analyzed by Leica FW4000 software (Leica Microsystems).
Statistical analysis. Our data mostly meet the assumptions of the tests (normal distribution). Statistical significance was analyzed by two-tailed unpaired t tests, in which the variances of the groups are similar. A value of P < 0.05 was considered statistically significant. All the data shown in this study are the mean ± SEM from at least three biological replicates.
Data availability. Mass spectrometry proteomics data that support the findings of this study have been deposited in the ProteomeXchange Consortium via the PRIDE partner repository with the accession code PXD007050. The authors declare that all other data are available from the corresponding authors upon request.
